Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 2
1969 3
1971 3
1972 3
1973 1
1974 5
1975 16
1976 26
1977 28
1978 28
1979 23
1980 27
1981 32
1982 31
1983 35
1984 34
1985 38
1986 39
1987 32
1988 31
1989 44
1990 62
1991 45
1992 45
1993 44
1994 49
1995 48
1996 44
1997 59
1998 56
1999 31
2000 57
2001 65
2002 50
2003 60
2004 69
2005 83
2006 66
2007 97
2008 113
2009 127
2010 138
2011 143
2012 152
2013 161
2014 143
2015 129
2016 162
2017 172
2018 168
2019 182
2020 252
2021 272
2022 255
2023 241
2024 109

Text availability

Article attribute

Article type

Publication date

PubMed for id: 39327

3,977 results

Results by year

Filters applied: . Clear all
Page 1
Real-world non-interventional post-authorization safety study of long-term use of burosumab in children and adolescents with X-linked hypophosphatemia: first interim analysis.
M Boot A, Ariceta G, Beck-Nielsen SS, Brandi ML, Briot K, Collantes CL, Giannini S, Haffner D, Keen R, Levtchenko E, Mughal MZ, Makitie O, Nilsson O, Schnabel D, Tripto-Shkolnik L, Zillikens MC, Liu J, Tudor A, Emma F. M Boot A, et al. Ther Adv Chronic Dis. 2024 May 18;15:20406223241247643. doi: 10.1177/20406223241247643. eCollection 2024. Ther Adv Chronic Dis. 2024. PMID: 38764445 Free PMC article.
Genetic causes of hypophosphatemia.
Puente N, Solis P, Riancho JA. Puente N, et al. Minerva Med. 2024 May 9. doi: 10.23736/S0026-4806.24.09198-5. Online ahead of print. Minerva Med. 2024. PMID: 38727708
Burosumab vs conventional therapy in children with X-linked hypophosphatemia: results of the open-label, phase 3 extension period.
Ward LM, Högler W, Glorieux FH, Portale AA, Whyte MP, Munns CF, Nilsson O, Simmons JH, Padidela R, Namba N, Cheong HI, Sochett E, Muroya K, Tanaka H, Pitukcheewanont P, Gottesman GS, Biggin A, Perwad F, Chen A, Lawrence Merritt Ii J, Imel EA. Ward LM, et al. JBMR Plus. 2024 Jan 4;8(1):ziad001. doi: 10.1093/jbmrpl/ziad001. eCollection 2024 Jan. JBMR Plus. 2024. PMID: 38690124 Free PMC article. Clinical Trial.
3,977 results